COCO
The Vita Coco Company, Inc. NASDAQ Listed Oct 21, 2021$68.16
After hrs
$70.73
-1.22%
Mkt Cap $3.9B
52w Low $30.54
96.4% of range
52w High $69.58
50d MA $53.89
200d MA $47.54
P/E (TTM)
53.4x
EV/EBITDA
33.8x
P/B
11.5x
Debt/Equity
0.0x
ROE
23.5%
P/FCF
77.3x
RSI (14)
—
ATR (14)
—
Beta
0.47
50d MA
$53.89
200d MA
$47.54
Avg Volume
1.4M
The Vita Coco Company, Inc. develops, markets, and distributes coconut water products under the Vita Coco brand name in the United States, Canada, Europe, the Middle East, and the Asia Pacific. The company offers coconut oil and coconut milk; Hydration Drink Mix, a powdered form of flavored coconut water; sparkling water; Runa, a plant-based energy drink; purified water under the Ever & Ever brand name; and PWR LIFT, a protein-infused fitness drink. It distributes its products through club, food, drug, mass, convenience, e-commerce, and foodservice channels. In addition, the company supplies coconut water and coconut oil categories to retailers. The company was formerly known as All Market Inc. and changed its name to The Vita Coco Company, Inc. in September 2021.The Vita Coco Company, Inc. was founded in 2004 and is headquartered in New York, New York.
250 Park Avenue South · New York City, NY 10003 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | BMO | 0.34 | 0.50 | +47.1% | 51.63 | +17.4% | +29.7% | +27.8% | +29.3% | +30.3% | +31.3% | — |
| Feb 18, 2026 | BMO | 0.13 | 0.09 | -30.8% | 56.52 | -2.6% | -11.4% | -8.4% | -4.5% | -5.1% | -2.3% | — |
| Oct 29, 2025 | BMO | 0.32 | 0.40 | +25.0% | 42.24 | +9.8% | +7.2% | +0.9% | -2.5% | -3.4% | -5.6% | — |
| Jul 30, 2025 | BMO | 0.36 | 0.38 | +5.6% | 36.77 | +1.8% | +0.0% | -4.1% | -5.5% | -7.9% | -12.2% | — |
| Apr 30, 2025 | BMO | 0.22 | 0.31 | +40.9% | 31.55 | -1.4% | +4.8% | +6.1% | +8.4% | +10.3% | +10.9% | — |
| Feb 26, 2025 | BMO | 0.08 | 0.12 | +50.0% | 38.16 | -12.9% | -11.7% | -15.6% | -15.0% | -14.1% | -12.6% | — |
| Oct 30, 2024 | BMO | 0.26 | 0.32 | +23.1% | 30.78 | +0.7% | -4.0% | -3.8% | +3.9% | +12.4% | +14.6% | — |
| Jul 31, 2024 | BMO | 0.29 | 0.32 | +10.3% | 24.63 | +5.6% | +4.9% | +7.8% | +11.0% | +6.8% | +5.3% | — |
| May 1, 2024 | BMO | 0.17 | 0.24 | +41.2% | 24.24 | +0.0% | +7.9% | +9.2% | +9.4% | +8.8% | +7.3% | — |
| Feb 28, 2024 | BMO | 0.08 | 0.11 | +37.5% | 22.43 | +15.7% | +14.9% | +16.4% | +16.6% | +16.7% | +13.9% | — |
| Oct 31, 2023 | BMO | 0.25 | 0.26 | +4.0% | 23.37 | +11.0% | +16.0% | +20.0% | +21.9% | +23.8% | +23.7% | — |
| Aug 2, 2023 | BMO | 0.18 | 0.31 | +72.2% | 26.39 | +9.7% | -5.0% | -7.2% | -6.9% | +4.5% | +1.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12 | Piper Sandler | Downgrade | Overweight → Neutral | — | $30.42 | $29.19 | -4.0% | -9.1% | -9.6% | -9.3% | -12.9% | -14.8% |
| Jul 10 | Wells Fargo | Maintains | Overweight → Overweight | — | $28.25 | $28.53 | +1.0% | +6.7% | +7.7% | -2.1% | -2.7% | -2.3% |
| Jul 10 | BofA Securities | Maintains | Neutral → Neutral | — | $28.25 | $28.53 | +1.0% | +6.7% | +7.7% | -2.1% | -2.7% | -2.3% |
| May 23 | Stephens & Co. | Maintains | Overweight → Overweight | — | $26.23 | $26.25 | +0.1% | +0.4% | +0.0% | +2.7% | +3.6% | +6.9% |
| Feb 29 | Piper Sandler | Maintains | Overweight → Overweight | — | $25.77 | $26.50 | +2.8% | +1.3% | +1.5% | +1.6% | -0.9% | -1.9% |
| Jan 31 | Goldman Sachs | Maintains | Buy → Buy | — | $20.24 | $20.14 | -0.5% | -2.7% | -0.9% | -1.5% | -3.1% | -3.4% |
| Jan 30 | Goldman Sachs | Maintains | Buy → Buy | — | $20.64 | $20.55 | -0.4% | -1.9% | -4.6% | -2.8% | -3.4% | -5.0% |
| Jan 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $20.96 | $20.82 | -0.7% | -4.2% | -1.5% | -3.4% | -6.1% | -4.3% |
| Jan 22 | William Blair | Downgrade | Outperform → Market Perform | — | $22.36 | $21.50 | -3.8% | -6.1% | -6.2% | -6.6% | -6.3% | -10.2% |
| Nov 1 | Piper Sandler | Maintains | Overweight → Overweight | — | $27.10 | $27.74 | +2.4% | +3.5% | +5.1% | +6.8% | +6.7% | +2.7% |
| Oct 17 | BofA Securities | Maintains | Neutral → Neutral | — | $26.91 | $26.28 | -2.3% | -4.7% | -7.0% | -8.0% | -8.9% | -7.6% |
| Aug 3 | BofA Securities | Downgrade | Buy → Neutral | — | $25.07 | $24.41 | -2.6% | -2.3% | -2.0% | +10.1% | +6.3% | +5.6% |
| Aug 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $25.07 | $24.41 | -2.6% | -2.3% | -2.0% | +10.1% | +6.3% | +5.6% |
| Aug 3 | Goldman Sachs | Maintains | Buy → Buy | — | $25.07 | $24.41 | -2.6% | -2.3% | -2.0% | +10.1% | +6.3% | +5.6% |
| May 4 | Goldman Sachs | Maintains | Buy → Buy | — | $23.62 | $24.00 | +1.6% | -2.9% | -4.1% | -1.5% | +3.1% | +3.1% |
| May 4 | Wells Fargo | Maintains | Overweight → Overweight | — | $23.62 | $24.00 | +1.6% | -2.9% | -4.1% | -1.5% | +3.1% | +3.1% |
| May 4 | Craig-Hallum | Maintains | Buy → Buy | — | $23.62 | $24.00 | +1.6% | -2.9% | -4.1% | -1.5% | +3.1% | +3.1% |
| Apr 18 | Goldman Sachs | Maintains | Buy → Buy | — | $21.50 | $21.53 | +0.1% | -3.5% | -3.7% | -3.8% | -3.8% | -5.5% |
| Apr 17 | Goldman Sachs | Maintains | Buy → Buy | — | $21.39 | $21.71 | +1.5% | +0.5% | -3.0% | -3.2% | -3.3% | -3.3% |
| Apr 5 | Craig-Hallum | Maintains | Buy → Buy | — | $19.60 | $20.25 | +3.3% | +6.3% | +6.0% | +11.8% | +10.6% | +9.2% |
| Mar 9 | Goldman Sachs | Maintains | Buy → Buy | — | $16.49 | $16.90 | +2.5% | +6.9% | +2.5% | +0.5% | -0.2% | +2.9% |
| Mar 9 | Wells Fargo | Maintains | Overweight → Overweight | — | $16.49 | $16.90 | +2.5% | +6.9% | +2.5% | +0.5% | -0.2% | +2.9% |
| Mar 9 | Credit Suisse | Maintains | Outperform → Outperform | — | $16.49 | $16.90 | +2.5% | +6.9% | +2.5% | +0.5% | -0.2% | +2.9% |
| Jan 3 | Wells Fargo | Maintains | Overweight → Overweight | — | $13.82 | $14.11 | +2.1% | -2.3% | +0.7% | -0.1% | -2.5% | -1.3% |
| Dec 15 | Piper Sandler | Maintains | Overweight → Overweight | — | $13.25 | $13.25 | +0.0% | -0.8% | +2.3% | +1.3% | +2.2% | +3.2% |
| Nov 10 | Wells Fargo | Maintains | Overweight → Overweight | — | $8.31 | $8.70 | +4.7% | +21.5% | +29.0% | +30.0% | +29.5% | +27.6% |
| Oct 3 | Wells Fargo | Maintains | Overweight → Overweight | — | $11.39 | $11.39 | +0.0% | +3.0% | +8.6% | +7.1% | +8.2% | +4.9% |
| Aug 11 | Credit Suisse | Maintains | Outperform → Outperform | — | $12.32 | $12.64 | +2.6% | +4.2% | +6.5% | +24.7% | +27.7% | +24.1% |
| Jul 8 | BofA Securities | Upgrade | Neutral → Buy | — | $9.90 | $10.77 | +8.8% | +11.4% | +18.6% | +19.2% | +19.5% | +13.9% |
| May 16 | Piper Sandler | Maintains | Overweight → Overweight | — | $10.38 | $10.38 | +0.0% | -1.3% | +2.2% | -6.8% | -3.0% | +0.9% |
| May 12 | Credit Suisse | Maintains | Outperform → Outperform | — | $9.99 | $9.41 | -5.8% | -9.1% | +3.9% | +2.6% | +6.2% | -3.2% |
| May 12 | Goldman Sachs | Maintains | Buy → Buy | — | $9.99 | $9.41 | -5.8% | -9.1% | +3.9% | +2.6% | +6.2% | -3.2% |
| Apr 4 | Goldman Sachs | Maintains | Buy → Buy | — | $9.11 | $9.11 | +0.0% | -1.1% | -2.3% | -4.1% | -2.5% | +1.1% |
| Mar 14 | BofA Securities | Downgrade | Buy → Neutral | — | $8.55 | $8.34 | -2.5% | -11.6% | -4.2% | +2.6% | +4.2% | +2.9% |
| Mar 11 | Credit Suisse | Maintains | Outperform → Outperform | — | $8.65 | $8.80 | +1.7% | -1.2% | -12.7% | -5.4% | +1.3% | +2.9% |
| Mar 11 | Wells Fargo | Maintains | Overweight → Overweight | — | $8.65 | $8.80 | +1.7% | -1.2% | -12.7% | -5.4% | +1.3% | +2.9% |
| Nov 15 | Piper Sandler | Maintains | Overweight → Overweight | — | $14.50 | $15.23 | +5.0% | +21.2% | +4.8% | +15.2% | +4.2% | +8.6% |
| Nov 15 | Credit Suisse | Maintains | Outperform → Outperform | — | $14.50 | $15.23 | +5.0% | +21.2% | +4.8% | +15.2% | +4.2% | +8.6% |
| Nov 15 | Evercore ISI | Maintains | Outperform → Outperform | — | $14.50 | $15.23 | +5.0% | +21.2% | +4.8% | +15.2% | +4.2% | +8.6% |
| Nov 15 | Wells Fargo | Maintains | Overweight → Overweight | — | $14.50 | $15.23 | +5.0% | +21.2% | +4.8% | +15.2% | +4.2% | +8.6% |
| Jun 19 | Gabelli & Co. | Downgrade | Hold → Sell | — | — | — | — | — | — | — | — | — |
| May 6 | Deutsche Bank | Maintains | Hold → Hold | — | — | — | — | — | — | — | — | — |
| Feb 5 | Compass Point | Maintains | Sell → Sell | — | — | — | — | — | — | — | — | — |
| Feb 4 | Gabelli & Co. | Downgrade | Buy → Hold | — | — | — | — | — | — | — | — | — |
| Nov 18 | Deutsche Bank | Maintains | Hold → Hold | — | — | — | — | — | — | — | — | — |
| Jan 30 | Piper Sandler | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| Oct 31 | Barclays | Maintains | Equal Weight → Equal Weight | — | — | — | — | — | — | — | — | — |
| Aug 26 | Topeka Capital | Maintains | Sell → Sell | — | — | — | — | — | — | — | — | — |
| Aug 20 | Topeka Capital | Maintains | Sell → Sell | — | — | — | — | — | — | — | — | — |
| Aug 20 | Piper Sandler | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | van Es CharlesOff | Chief Commercial Officer | Sell | 2,000 | $66.87 | $134K | 75,691 | +0.80% | — |
| Apr 30, 2026 | Kirban MichaelDir/Off | Executive Chairman | Sell | 50,000 | $68.00 | $3.4M | 515,681 | +0.75% | +7.27% |
| Apr 30, 2026 | Burth JonathanOff | Chief Operating Officer | Sell | 20,000 | $67.50 | $1.4M | 57,910 | +0.75% | +7.27% |
| Apr 29, 2026 | Roper MartinDir/Off | Chief Executive Officer | Sell | 20,544 | $59.35 | $1.2M | 298,484 | +1.15% | +3.36% |
| Apr 29, 2026 | Burth JonathanOff | Chief Operating Officer | Sell | 20,000 | $65.00 | $1.3M | 77,910 | +0.75% | +7.27% |
| Apr 28, 2026 | Roper MartinDir/Off | Chief Executive Officer | Sell | 25,000 | $51.13 | $1.3M | 298,484 | +1.15% | +3.36% |
| Apr 27, 2026 | Roper MartinDir/Off | Chief Executive Officer | Sell | 25,000 | $50.00 | $1.2M | 298,484 | +29.67% | +32.99% |
| Apr 24, 2026 | Roper MartinDir/Off | Chief Executive Officer | Sell | 25,000 | $50.00 | $1.2M | 298,484 | +29.67% | +32.99% |
8-K
The Vita Coco Company, Inc. -- 8-K Filing
Vita Coco (COCO) reported strong 37% net sales growth to $180 million with net income doubling to $30 million, raising full-year guidance to $720-735 million in sales and $132-138 million in adjusted EBITDA.
Apr 29
8-K
The Vita Coco Company, Inc. -- 8-K Filing
Vita Coco Company filed an 8-K reporting standard corporate disclosure obligations under Exchange Act Section 12(b)-2, with no material operational or financial developments announced in this filing.
Apr 22
8-K
Unknown — 8-K Filing
COCO likely filed routine regulatory disclosure updates required for exchange-listed companies, which carries minimal stock impact unless it signals a material business change or emerging growth company status reclassification.
Apr 10
8-K
The Vita Coco Company, Inc. -- 8-K Filing
Vita Coco (COCO) delivered strong 2025 results with 18% sales growth to $610 million and raised 2026 guidance to $680-700 million, signaling continued momentum in coconut water demand.
Feb 18
Data updated apr 25, 2026 2:26am
· Source: massive.com